Table 5.
Haplotype structure and frequency analysis of BTNL2 genetic polymorphisms between dilated cardiomyopathy (DCM) patients and controls
| Haplotype | Frequency | x2-test | OR (95% CI) | P-value | |
|---|---|---|---|---|---|
|
| |||||
| DCM (2n = 164) | Control (2n = 150) | ||||
| C-A-A-C | 18 (0.1098) | 17 (0.1165) | 0.042 | 1.07 (0.53, 2.20) | 0.837 |
| C-A-C-T | 10 (0.0595) | 6 (0.0383) | 1.10 | 1.73 (0.61, 4.92) | 0.295 |
| G-C-A-T | 11 (0.0647) | 10 (0.0665) | 0.069 | 1.13 (0.46, 2.75) | 0.792 |
| G-A-A-C | 12 (0.0702) | 6 (0.0409) | 2.24 | 2.13 (0.78, 5.87) | 0.132 |
| G-A-A-T | 15 (0.0931) | 9 (0.0614) | 2.22 | 1.78 (0.75, 4.23) | 0.186 |
| G-C-A-C | 8 (0.0488) | 6 (0.0443) | 0.33 | 1.38 (0.46, 4.08) | 0.563 |
| C-A-A-T | 23 (0.1456) | 26 (0.1747) | 0.17 | 0.88 (0.47, 1.63) | 0.677 |
| C-C-A-T | 16 (0.1012) | 29 (0.1893) | 4.28 | 0.50 (0.26, 0.97) | 0.038 |
| C-C-A-C | 12 (0.0763) | 19 (0.1262) | 1.67 | 0.61 (0.28, 1.30) | 0.196 |
| C-C-C-T | 7 (0.0413) | 6 (0.0415) | 0.097 | 1.20 (0.39, 3.66) | 0.760 |
OR, odds ratio; CI, confidence interval.